Horiba for Healthcare

28/08/2026

In this short video, Dr. Gulnaz Zhumagualieva, Head of the Laboratory at Sayram Central District Hospital, shares her experience after nearly six years of using the semi-automated hemostasis analyzer Yumizen G400 she introduced, and explains how evolving requirements are shaping future automation plans.
👉Discover the Yumizen hemostasis solutions here: https://eu1.hubs.ly/H0xV7_30

25/08/2026

As antibiotic-resistant infections continue to increase worldwide, healthcare professionals face the challenge of preserving treatment effectiveness while ensuring optimal patient care.
Discover the drivers behind AMR and explore how evidence-based diagnostic approaches can support responsible antibiotic use.
🔗 Read the full whitepaper here: https://eu1.hubs.ly/H0xLQ0z0

20/08/2026

How does the Yumizen H550 support routine hematology testing?

In this 1-minute video, Ms Paola Michel González Hernández, Head of the Hematology Department at a laboratory in Durango, Mexico, shares her experience using the Yumizen H550 in daily practice.

What you'll learn
▪️The benefits observed in day-to-day hematology operations
▪️Why the analyzer supports efficient blood cell analysis and clinical decision-making

▶️ Watch the 1-minute laboratory testimonial
Hear directly from a laboratory professional about their experience with the Yumizen H550 and how it supports their daily work.

19/08/2026

✅ Quiz Answer: B
The extensive platelet clumping suggests that the low EDTA platelet count may be falsely reduced due to pseudothrombocytopenia.
Repeating the test using sodium citrate can help prevent EDTA-dependent aggregation and provide a more reliable result.
The citrate blood smear should also be checked to confirm that the clumping has resolved, and the result should be reported according to the laboratory’s validated procedure.

Dig deeper into the blood and blood disorders in our hematology newsletter, which focuses on blood morphology bringing you case studies & slide reviews, hemostasis, technologies, clinical advancements, and quizzes: https://www.horiba.com/int/healthcare/heme-insights/heme-insights-8?utm_source=facebook&utm_medium=share&utm_campaign=hmfr-healthcare-hemeinsights-2025&utm_term=8-quiz-answer&utm_content=19082026

It's quiz time with !

A patient’s EDTA sample gives a platelet count of 41 × 10⁹/L. The analyzer flags possible platelet clumps, and the blood smear shows aggregates. What is the most appropriate next step?

a) Report severe thrombocytopenia immediately.
b) Request a correctly collected citrate sample and analyze it promptly.
c) Issue a normal platelet result based on the smear estimate.
d) Ignore the clumps and repeat the EDTA count the next day.

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://eu1.hubs.ly/H0xlZKZ0

18/08/2026

🔬 New Chase the Case #59: Chronic Lymphocytic Leukemia (CLL)

In this month's Chase the Case, discover a clinical case of Chronic Lymphocytic Leukemia (CLL) and review the analyzer patterns, blood smear findings, and key observations that contributed to the diagnosis.

✅View the case on the website: https://eu1.hubs.ly/H0xHT7Y0
✅Subscribe: https://eu1.hubs.ly/H0xHTjh0

11/08/2026

It's quiz time with !

A patient’s EDTA sample gives a platelet count of 41 × 10⁹/L. The analyzer flags possible platelet clumps, and the blood smear shows aggregates. What is the most appropriate next step?

a) Report severe thrombocytopenia immediately.
b) Request a correctly collected citrate sample and analyze it promptly.
c) Issue a normal platelet result based on the smear estimate.
d) Ignore the clumps and repeat the EDTA count the next day.

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://eu1.hubs.ly/H0xlZKZ0

06/08/2026

Advancing innovation in healthcare through precision measurement

The latest issue of HORIBA Readout explores how advanced analysis and measurement technologies are shaping the future of healthcare.

From diagnostics and drug discovery to cell therapies, metabolomics, and cancer management, this edition highlights innovations driving faster, more accurate, and more accessible care.

👉 Read the full issue: https://bit.ly/4gIiD9N

04/08/2026

A severely reduced platelet count can immediately raise concerns, but what if the result does not reflect the patient's true condition?

In the latest issue of , we explore a case where apparent thrombocytopenia was caused by platelet aggregation rather than a genuine decrease in circulating platelets.

Follow the diagnostic pathway from analyzer review and blood smear examination to repeat testing and result reporting, while discovering practical recommendations to help ensure accurate laboratory interpretation and patient safety.

👉Read on the website, find back issues, and subscribe: https://eu1.hubs.ly/H0xlVwl0

28/07/2026

This , we recognize the importance of awareness, screening, and timely diagnosis to help reduce the burden of liver disease worldwide.

Reliable laboratory testing is essential for the detection, assessment, and monitoring of liver diseases. HORIBA clinical chemistry analyzers provide access to a broad range of liver function and hepatitis-related parameters, helping healthcare professionals make informed clinical decisions throughout the patient journey.

27/07/2026

The next issue of , HORIBA’s hematology newsletter, is arriving in August—and you won’t want to miss it!

Whether you're in clinical diagnostics, laboratory management, or hematology research—or just beginning your journey in the field—HemeInsights delivers expert perspectives, real-world case studies, and technology updates tailored to your needs.

📬 If you haven't subscribed yet, subscribe now and get HemeInsights delivered from the next issue: https://eu1.hubs.ly/H0x827C0